Optimizing dosage and duration therapy for chronic hepatitis C «difficult-to-treat patients»

Journal Title: Annals of Hepatology - Year 2008, Vol 7, Issue 4

Abstract

Authors and Affiliations

José Ladero

Keywords

Related Articles

Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma

Introduction. Considering the high prevalence of liver tumors and the impact on patient survival, a greater understanding of the biological behavior of those tumors if of great importance. The multidrug resistance gene (...

Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome

Background. Liver transplantation is often associated with metabolic derangements. Adipocyte fatty-acid-binding protein 4 (AFABP4) integrates inflammatory and metabolic responses. It has also been associated with metabol...

Thrombopoietin level in patients with chronic liver diseases

Thrombocytopenia and oxidative stress are the most frequent problems in patients with chronic liver diseases as viral cirrhosis and schistosomiasis. So, this study aimed to evaluate the role of thrombopoietin (TPO) on th...

Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Background. The evolving pattern of HCV genotypes (GTs) and risk factors (RFs) in HCV-infected patients in Mexico is poorly understood. This study aimed to access the temporal trend of HCV GTs and RFs in HCV patients fro...

Download PDF file
  • EP ID EP77818
  • DOI -
  • Views 149
  • Downloads 0

How To Cite

José Ladero (2008). Optimizing dosage and duration therapy for chronic hepatitis C «difficult-to-treat patients». Annals of Hepatology, 7(4), 392-394. https://europub.co.uk/articles/-A-77818